Saturday, June 12, 2010

FDA official attacks safety of diabetes drug

And Avandia has been around for a while.
The diabetes drug Avandia, known generically as rosiglitazone, exposed patients to greater health risks including heart attacks, and even death, the Wall Street Journal said, citing a U.S. Food and Drug Administration scientist's study.

Patients in the U.S. Medicare system who took the drug may have suffered as many as 48,000 heart attacks, strokes and other problems between 1999 and 2009 that could have been averted had they taken a different drug, the study concluded.
You can bet that the IMHO malpractice known as diet drugs will also have more and more reports of complications.

Better to be fit than drugged.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.